Pharma


 Novartis launches new share buyback for up to 10% of its stock

Novartis launches new share buyback for up to 10% of its stock

March 13, 2023 05:19 PM AEDT | By Reuters

ZURICH (Reuters) - Novartis has launched a new share buyback programme to purchase up to 10% of the pharma company's own shares over the next three ye...

 Britain's NICE to speed up reviews of COVID-19 treatments

Britain's NICE to speed up reviews of COVID-19 treatments

February 16, 2023 11:39 AM AEDT | By Reuters

(Corrects to remove erroneous word in headline) By Maggie Fick LONDON (Reuters) - Britain's agency that determines if medicines should be used in the...

 Indonesia court hears class-action suit after children die from tainted cough syrup

Indonesia court hears class-action suit after children die from tain...

January 17, 2023 07:33 PM AEDT | By Reuters

JAKARTA (Reuters) - Families of Indonesian children who died because of tainted cough syrup demanded restitution as an Indonesian court on Tuesday sta...

 AstraZeneca signs COVID treatment deal with China's Genertec Meheco

AstraZeneca signs COVID treatment deal with China's Genertec Meheco

January 13, 2023 09:00 PM AEDT | By Reuters

BEIJING (Reuters) - AstraZeneca has signed a cooperation agreement with China's Genertec Meheco for COVID-19 antibody drug Evusheld, it said on Friday...

 U.S. to announce list of drugs for pricing negotiations Sept. 1

U.S. to announce list of drugs for pricing negotiations Sept. 1

January 12, 2023 03:11 AM AEDT | By Reuters

By Ahmed Aboulenein WASHINGTON (Reuters) - The U.S. government will announce a list of 10 prescription drugs for which it plans to negotiate the price...

 U.S. extends COVID-19 public health emergency status - CNBC

U.S. extends COVID-19 public health emergency status - CNBC

January 12, 2023 02:42 AM AEDT | By Reuters

(Reuters) -The United States on Wednesday extended the COVID-19 pandemic's status as a public health emergency until April, CNBC reported on Wednesday...

 U.S. FDA grants priority review to Roche's bispecific antibody Glofitamab

U.S. FDA grants priority review to Roche's bispecific antibody Glofi...

January 06, 2023 05:34 PM AEDT | By Reuters

ZURICH (Reuters) - Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company's b...

 Japan's Meiji Holdings says drug unit started late-stage trial for COVID vaccine

Japan's Meiji Holdings says drug unit started late-stage trial for C...

December 13, 2022 05:47 PM AEDT | By Reuters

TOKYO (Reuters) - Japan's Meiji Holdings Co said on Tuesday its drug subsidiary had started a Phase III trial of an mRNA-based vaccine for COVID-19. M...

 Malaria deaths dip in 2021 after rising in first year of COVID, says WHO

Malaria deaths dip in 2021 after rising in first year of COVID, says...

December 08, 2022 10:17 PM AEDT | By Reuters

By Pratik Jain (Reuters) - Malaria-related deaths fell slightly in 2021 after a significant increase in the first year of COVID-19, but remained highe...

 Analysis-U.S. midterms dampen Big Pharma hopes for drug price policy change

Analysis-U.S. midterms dampen Big Pharma hopes for drug price policy...

November 19, 2022 06:18 AM AEDT | By Reuters

By Ahmed Aboulenein WASHINGTON (Reuters) - The divided U.S. Congress after the November midterm elections undermines pharmaceutical companies who want...

 Cancer diagnoses lag after screenings fall during pandemic, U.S. study finds

Cancer diagnoses lag after screenings fall during pandemic, U.S. stu...

November 18, 2022 03:28 AM AEDT | By Reuters

By Shawana Alleyne-Morris (Reuters) - Screenings for a variety of common cancers have not returned to pre-pandemic levels, potentially leading to diag...

 Big pharma not doing enough to improve drug access - analysis

Big pharma not doing enough to improve drug access - analysis

November 16, 2022 12:04 AM AEDT | By Reuters

By Natalie Grover LONDON (Reuters) - Since the pandemic emerged, more top drugmakers have made progress in improving access to medicines in the develo...

 AstraZeneca tops quarterly estimates buoyed by cancer drugs

AstraZeneca tops quarterly estimates buoyed by cancer drugs

November 10, 2022 09:46 PM AEDT | By Reuters

By Natalie Grover (Reuters) - AstraZeneca on Thursday raised its full-year adjusted earnings forecast after third-quarter profit and revenue topped an...

Recent Articles

 Aviation Gasoline (Avgas) Market | North America Fastest Growing by Canada, US
December 08, 2023 10:00 PM AEDT | By EIN Presswire

 Layflat.com announces five regional training centers
December 05, 2023 06:00 PM AEDT | By EIN Presswire

 Stefan Blomsterberg appointed as new CEO of CELLINK Bioprinting AB
December 04, 2023 08:00 PM AEDT | By EIN Presswire

 Sweden-Based Crypto Tax Tool Kryptos announces ‘Elite Partners’ Program
November 25, 2023 08:00 AM AEDT | By EIN Presswire

 Sweden-based Crypto Tax Software- Kryptos Introduces Revolutionary AI Features for Easier Tax Filing
November 24, 2023 07:03 PM AEDT | By EIN Presswire


Top LSE Listed Companies